A team that manages a specialized facility for biophysical research.
Official title: The Biophysics Collaborative Access Team (Admin - Core)
Funded at Illinois Institute of Technology · NIH-11009530 · Data updated 2026-11-12
This study is all about using special tools to help scientists look closely at tiny biological materials, which could lead to better understanding of diseases and new treatments that might help patients like you in the future.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Illinois Institute of Technology NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | February 1, 2021 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $239,855 |
| NIH project number | 5P30GM138395-05 |
| Project ID | NIH-11009530 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that could be better understood through biophysical analysis, such as cancer or genetic disorders.
✕Less likely to help
Patients with conditions unrelated to biophysical sciences or those not requiring advanced imaging techniques may not receive direct benefits from this research.
What this research studies
The Biophysics Collaborative Access Team (BioCAT) operates a synchrotron beamline that provides researchers with advanced tools to study biological materials at a molecular level. This facility allows scientists to conduct experiments that require high-resolution imaging and analysis of biological samples. The team ensures efficient scheduling and access to the beamline, while also maintaining safety protocols and providing administrative support for research activities. Patients may benefit indirectly through advancements in biophysical sciences that could lead to improved understanding of diseases and development of new therapies.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding biological processes and diseases, ultimately improving patient care and treatment options.
How similar studies have gone: Other research utilizing synchrotron facilities has shown significant success in advancing our understanding of biological systems, indicating that this approach is well-established and promising.
Where this research is happening
-
Illinois Institute of Technology
Chicago, United States Active
Researchers
- Principal investigator: Irving, Thomas C — Illinois Institute of Technology
- Study coordinator: Irving, Thomas C
Related research
Other NIH-funded projects on the same topics.
-
Intraoperative margin check for head and neck cancer during surgery
A new imaging and automated analysis tool is being tested during head and neck cancer surgeries to check the bottom edge of the removed tissue in under a minute.
-
Food safety research hub that collaborates to protect the public from contaminated or misrepresented foods
A large, ongoing U.S. collaboration is advancing food safety and nutrition through joint work among academia, industry, and FDA to protect consumers.
-
Identifying where harmful bacteria hide in Illinois
This grant aims to map where dangerous bacteria live in the environment in Illinois so we can stop them from getting into food.
-
Gender-affirming counseling to reduce stigma, HIV risk, and substance use in transgender women
A new program adapts Acceptance and Commitment Therapy to be led by peers, aiming to reduce internalized stigma and distress and lower substance use and HIV risk for transgender women.
-
Antibody-based targeted radiotherapy for triple-negative breast cancer
This grant aims to develop antibody chelator conjugates that deliver radioactive therapy directly to TNBC cells, potentially offering a new option for patients who have few effective treatments.
-
Gender-affirming program to reduce stigma, substance use, and HIV risk for transgender women
This program teaches gender-affirming coping skills to transgender women to reduce stigma-related distress, lower substance use, and reduce behaviors that increase HIV risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.